Thursday, December 8, 2011

Patent Issued for Treatment of Diabetes

Denver, Colorado based Omni Bio Pharmaceutical, Inc. confirms announcement from U.S. Patent Office. DENVER, Dec. 8, 2011 /PRNewswire/ -- Omni Bio Pharmaceutical, Inc. ("Omni Bio") (OTC OMBP.OB) today announced that U.S. Patent No. 8,071,551, entitled "METHODS AND COMPOSITIONS FOR TREATING DIABETES," was issued by the United States Patent and Trademark Office on December 6, 2011 (the "Diabetes Patent"). The Diabetes Patent expires in May 2022. The Diabetes Patent is the most recently issued ...continued
 

No comments:

Post a Comment